Which hedge funds own TLX? TELIX PHARMACEUTICAL LTD, Q2 2026 13F holders
5 of the hedge funds tracked by WhaleCreep disclosed a position in TLX (TELIX PHARMACEUTICAL LTD) in their Q2 2026 13F filings, worth $3.1m in total. The largest holder by portfolio weight is Capricorn Fund Managers LTD at 0.0% of its book. 4 managers opened a new position this quarter: Capricorn Fund Managers LTD, SummitTX Capital, L.P., Marshall Wace, LLP, Two Sigma Investments, LP. 1 exited: Schonfeld Strategic Advisors LLC.
5tracked managers holding
4opened this quarter
1exited this quarter
Which hedge funds hold TLX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Capricorn Fund Managers LTD | Q2 2026 | 0.0% | $416.2k | 36,100 | – | new |
| SummitTX Capital, L.P. | Q2 2026 | 0.0% | $364.6k | 31,621 | – | new |
| Marshall Wace, LLP | Q2 2026 | 0.0% | $2.2m | 189,188 | – | new |
| Cva Family Office, LLC | Q2 2026 | 0.0% | $1.5k | 127 | 0% | held |
| Two Sigma Investments, LP | Q2 2026 | 0.0% | $118.0k | 10,233 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 0.0% | $333.7k |
How has hedge fund ownership of TLX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $3.1m |
| Q1 2026 | 2 | $334.9k |
| Q4 2025 | 1 | $137.9k |
Counts every tracked manager that disclosed TLX in that quarter's filing, including managers that have since stopped filing.